MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$73,657K
Cash and cash
equivalents
$30,649K
Prepaid expenses and
other current assets
$2,684K
Total current assets
$106,990K
Total assets
$106,990K
Total liabilities and
stockholders' equity
$106,990K
Total stockholders'
equity
$100,930K
Total liabilities
$6,060K
Accumulated deficit
-$972,345K
Additional
paid-in-capital
$1,072,666K
Total current
liabilities
$6,060K
Common stock,
value-Common Stock Class...
$347K
Common stock,
value-Nonvoting Common Stock
$254K
Accumulated other
comprehensive income
$8K
Accrued liabilities
$3,662K
Accounts payable
$2,398K
Back
Back
Balance Sheet
source: myfinsight.com
IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc. (IGMS)